tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PCKROMA Stock Latest News

Genomic Integrity Demand Rises With Commercial Progress in Cell and Gene Therapy
Private CompaniesGenomic Integrity Demand Rises With Commercial Progress in Cell and Gene Therapy
5d ago
KROMA
Evolving Genomic Analysis Needs in Cell and Gene Therapy Highlight Market for Advanced Tools
PremiumPrivate Companies
Evolving Genomic Analysis Needs in Cell and Gene Therapy Highlight Market for Advanced Tools
5d ago
KROMA
Genomic Integrity Focus Signals Potential Demand for KROMATID Edit Risk Assessments
PremiumPrivate Companies
Genomic Integrity Focus Signals Potential Demand for KROMATID Edit Risk Assessments
6d ago
KROMA
Genomic Risk Assessment Demand Highlighted in Gene Editing Quality Control
PremiumPrivate Companies
Genomic Risk Assessment Demand Highlighted in Gene Editing Quality Control
6d ago
KROMA
KROMATID Highlights Genomic Integrity Expertise in CRISPR-Edited Stem Cell Therapies
PremiumPrivate Companies
KROMATID Highlights Genomic Integrity Expertise in CRISPR-Edited Stem Cell Therapies
11d ago
KROMA
Early Genomic Integrity Testing Emerges as Focus in Cell Therapy Development
PremiumPrivate CompaniesEarly Genomic Integrity Testing Emerges as Focus in Cell Therapy Development
12d ago
KROMA
Cell Therapy Development Risks Underscore Need for Genomic Integrity Monitoring
Premium
Private Companies
Cell Therapy Development Risks Underscore Need for Genomic Integrity Monitoring
12d ago
KROMA
KROMATID Highlights Need for Comprehensive Genomic QC in Gene Editing
Premium
Private Companies
KROMATID Highlights Need for Comprehensive Genomic QC in Gene Editing
13d ago
KROMA
KROMATID Highlights Genomic Analysis Applications for Cell and Gene Therapy
PremiumPrivate Companies
KROMATID Highlights Genomic Analysis Applications for Cell and Gene Therapy
20d ago
KROMA
KROMATID Highlights Expanded Genomic Analysis Use Cases for Cell and Gene Therapy
PremiumPrivate Companies
KROMATID Highlights Expanded Genomic Analysis Use Cases for Cell and Gene Therapy
20d ago
KROMA
FDA Draft Guidance on Ultra-Rare Disease Therapies May Bolster Demand for KROMATID Genomic Services
PremiumPrivate Companies
FDA Draft Guidance on Ultra-Rare Disease Therapies May Bolster Demand for KROMATID Genomic Services
26d ago
KROMA
KROMATID Showcases Genomic Integrity Tools for CRISPR HSC Therapies
PremiumPrivate Companies
KROMATID Showcases Genomic Integrity Tools for CRISPR HSC Therapies
26d ago
KROMA
KROMATID Showcases Genomic Integrity Expertise for CRISPR HSC Therapies
PremiumPrivate CompaniesKROMATID Showcases Genomic Integrity Expertise for CRISPR HSC Therapies
27d ago
KROMA
KROMATID Spotlights Genomic Integrity Strategies for CRISPR HSC Therapy Development
Premium
Private Companies
KROMATID Spotlights Genomic Integrity Strategies for CRISPR HSC Therapy Development
27d ago
KROMA
KROMATID Highlights Genomic Integrity Focus in CRISPR HSC Therapy Webinar
Premium
Private Companies
KROMATID Highlights Genomic Integrity Focus in CRISPR HSC Therapy Webinar
27d ago
KROMA
Scientific Leadership Spotlight Supports KROMATID’s Genomic Analysis Positioning
PremiumPrivate Companies
Scientific Leadership Spotlight Supports KROMATID’s Genomic Analysis Positioning
1M ago
KROMA
KROMATID Executive Contributes to Key FISH Methodology Reference
PremiumPrivate Companies
KROMATID Executive Contributes to Key FISH Methodology Reference
1M ago
KROMA
Scientific Contribution Underscores KROMATID’s Position in Genomic Structural Analysis
PremiumPrivate Companies
Scientific Contribution Underscores KROMATID’s Position in Genomic Structural Analysis
1M ago
KROMA
KROMATID Executive Contributes to Key Reference on Advanced FISH Genomic Techniques
PremiumPrivate Companies
KROMATID Executive Contributes to Key Reference on Advanced FISH Genomic Techniques
1M ago
KROMA
KROMATID Emphasizes Culture and Talent as Drivers of Advanced Therapies Focus
PremiumPrivate CompaniesKROMATID Emphasizes Culture and Talent as Drivers of Advanced Therapies Focus
1M ago
KROMA
KROMATID Highlights People-Centered Culture as Strategic Asset in Advanced Therapies
Premium
Private Companies
KROMATID Highlights People-Centered Culture as Strategic Asset in Advanced Therapies
1M ago
KROMA
KROMATID Showcases Genomic Safety Focus in CRISPR HSC Therapy Webinar
Premium
Private Companies
KROMATID Showcases Genomic Safety Focus in CRISPR HSC Therapy Webinar
1M ago
KROMA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >